Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Potential use of pirfenidone in progressive renal disease

Nov. 27, 2002

Positive opinion for Levitra in E.U.

Nov. 26, 2002

FDA requests additional animal study before lifting Vasomax clinical hold

Nov. 26, 2002

Vivus initiates trial of VI-0162 in premature ejaculation

Nov. 25, 2002

AVI-4126 proves safe in PKD patients

Nov. 25, 2002

Ono reports prostanoid EP1 antagonists for urinary incontinence, pain, etc.

Nov. 22, 2002

Series of PDE5 inhibitors identified by Pfizer researchers

Nov. 21, 2002

Selective p38alpha MAPK inhibitor NPC-31145 improves outcome in glomerulonephritis

Nov. 19, 2002

First approval obtained for Cialis

Nov. 15, 2002

Novel substance P antagonists covered by Takeda patent

Nov. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...